Advanced BioPhotonics, Inc., a development stage company, engages in the development and commercialization of digital imaging technology for the diagnosis and management of various diseases, including cancer and vascular diseases in the United States. Its principal product includes BioScanIR system, which detects diseases that affect the perfusion or reperfusion of blood in tissues and organs. The BioScanIR system assists physicians and researchers in differentiating between normal and abnormal tissues by detecting small changes in perfusion. The company also develops advanced sensors through collaboration with aerospace and defense laboratories. The company was founded in 1997. It was formerly known as OmniCorder Technologies, Inc. and changed its name to Advanced BioPhotonics, Inc. in June 2005. Advanced BioPhotonics is headquartered in Bohemia, New York.